ESA use in CKD patients not on dialysis continues to decline - NephrOnline PDF Print
NephrOnlineIn the renal anemia market, the use of erythropoietin stimulating agents (ESAs) in patients with chronic kidney disease, not on dialysis (CKD-ND) continues

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.